Background: Routine axillary dissection in patients with invasive smal
l breast cancer remains controversial. We previously reported a model
for predicting nodal involvement in patients with T1a or T1b breast ca
ncer that may guide the practice of selective nodal dissection. The ob
jective of this study was to determine whether the prognosticators tha
t predict nodal metastases also predict survival. Study Design: This s
tudy is a retrospective review of 2,153 women with small invasive brea
st cancer (less than or equal to 1 cm) diagnosed between January 1984
and December 1995. Cases were identified from a statewide tumor regist
ry, the Hospital Association of Rhode Island, and the tumor registry a
t Baystate Medical Center in Massachusetts. The impact on survival of
patient age (less than or equal to 40 versus >40 years), nodal status
(positive versus negative), tumor size (T1a versus T1b), and tumor gra
de (1 versus 2 or 3) were analyzed. Breast cancer-specific survival (B
CSS) mas analyzed using the Kaplan-Meier method and the proportional h
azards regression method. Results: There were 388 patients with tumors
0.5 cm or less (T1a) and 1,765 with tumors 0.6-1.0 cm (T1b). Nodal st
atus was known in 68% of cases (1,461 of 2,153), and tumor grade was r
ecorded in 42% of cases (902 of 2,153). In univariate analysis, age, g
rade, and nodal status were significant in their association with BCSS
. Tumor size did not influence BCSS among patients with small invasive
tumors. Women older than 40 years had superior survival compared with
younger women (93% versus 78% at 5 years; p = 0.01). Similarly, women
with low grade (1) tumors did better than those with higher grade (2
or 3) tumors (98% versus 88% at 5 years; p = 0.03). The 5-year BCSS wa
s 96% versus 78% for node-negative versus node-positive disease, and t
he 10-year BCSS was 91% versus 62% (p = 0.001). In the multivariate an
alysis, age and nodal status remained firmly associated with survival,
although grade lost its significance. Conclusions: Small tumor size d
oes not affect survival. Although risk profiles for nodal involvement
can be constructed to help guide the practice of selective axillary ly
mphadenectomy in patients with small invasive breast cancers, these fa
ctors cannot serve as a surrogate to nodal status in establishing pati
ent prognosis. Nodal status remains the most powerful determinant of s
urvival in breast cancer patients, even those with very small tumors.
(C) 1998 by the American College of Surgeons.